JPH08198873A - Compound-selective fluorescent labeling reagent with sulfhydryl group - Google Patents
Compound-selective fluorescent labeling reagent with sulfhydryl groupInfo
- Publication number
- JPH08198873A JPH08198873A JP7031864A JP3186495A JPH08198873A JP H08198873 A JPH08198873 A JP H08198873A JP 7031864 A JP7031864 A JP 7031864A JP 3186495 A JP3186495 A JP 3186495A JP H08198873 A JPH08198873 A JP H08198873A
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- alkyl
- carbon atoms
- labeled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Luminescent Compositions (AREA)
Abstract
(57)【要約】
【目的】 高い蛍光量子効果を有し、位置選択的で、被
標識化合物の性質を変化させず、且つ簡便に標識できる
スルフヒドリル基を有する化合物選択性蛍光標識試薬。
【構成】 次の一般式
【化1】
(式中、R1 、R2 はそれぞれ独立に水素原子、アルキ
ル基、アルコキシル基又はスルホネート基であり、R3
はアルキル基、スルホン酸アルキル基又はアンモニオア
ルキル基であり、nは 1〜3 の整数で、Xはアニオン種
であり、Yは炭素数が 1〜10のアルキル鎖又は酸素原
子、窒素原子及び硫黄原子のいずれか 1種以上を含む炭
素数が 1〜10のアルキル鎖である。)で示される水溶性
インドシアニン化合物からなるスルフヒドリル基を有す
る化合物選択性蛍光標識試薬。
【効果】 分子内に一つのマレイミド基を有し、タンパ
ク等のスルフヒドリル基と反応して高感度の蛍光標識体
とする。被標識体を架橋させず、且つタンパクの特性を
損なわない。(57) [Abstract] [Objective] A compound-selective fluorescent labeling reagent having a sulfhydryl group, which has a high fluorescence quantum effect, is position-selective, does not change the properties of the compound to be labeled, and can be easily labeled. [Structure] The following general formula: (In the formula, R 1 and R 2 are each independently a hydrogen atom, an alkyl group, an alkoxyl group or a sulfonate group, and R 3
Is an alkyl group, an alkyl sulfonate group or an ammonioalkyl group, n is an integer of 1 to 3, X is an anion species, and Y is an alkyl chain having 1 to 10 carbon atoms or an oxygen atom, a nitrogen atom and An alkyl chain containing 1 to 10 carbon atoms and having 1 to 10 carbon atoms. ) A compound-selective fluorescent labeling reagent having a sulfhydryl group consisting of a water-soluble indocyanine compound represented by the formula (1). [Effect] Having one maleimide group in the molecule, it reacts with a sulfhydryl group of a protein or the like to obtain a highly sensitive fluorescent label. It does not crosslink the labeled substance and does not impair the properties of the protein.
Description
【0001】[0001]
【産業上の利用分野】本発明はスルフヒドリル基と反応
することにより蛍光ラベル化された化合物を高感度に検
出することのできるスルフヒドリル基を有する化合物選
択性蛍光標識試薬に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a compound-selective fluorescent labeling reagent having a sulfhydryl group capable of highly sensitively detecting a fluorescently labeled compound by reacting with a sulfhydryl group.
【0002】本発明の蛍光標識試薬はタンパクや核酸な
どの高分子の蛍光検出や高速液体クロマトグラフィー
(HPLC)による低分子化合物の検出に用いられる。The fluorescent labeling reagent of the present invention is used for fluorescence detection of polymers such as proteins and nucleic acids and detection of low molecular weight compounds by high performance liquid chromatography (HPLC).
【0003】[0003]
【従来の技術】スルフヒドリル基と反応できる蛍光標識
試薬は数多く知られており、マレイミド基、ヨードアセ
トアミドあるいはブロモアセトアミドが代表的な反応基
である。2. Description of the Related Art Many fluorescent labeling reagents capable of reacting with sulfhydryl groups are known, and maleimide group, iodoacetamide or bromoacetamide are typical reactive groups.
【0004】蛍光標識化合物としては、フルオレセイン
イソシアネート(FITC)、テトラメチルローダミンイソ
チオシアネート(TRITC )などがよく知られており、タ
ンパク分析や核酸分析の分野で広く用いられている。核
酸分析では、自動DNAシーケンサーでその塩基配列を
解析する際に、FITCやTRITC を標識したDNAオリゴマ
ーを用いたり、DNAの動的解析を行なう場合に使用し
たりしている。塩基配列解析の場合には、一般に電気泳
動後の各バンドに含まれるDNA断片の分子の数は約 1
×10-16 〜 1×10-18 であり、レーザーを光源とする光
学系を組合わせて検出できる限界である。Fluorescein isocyanate (FITC), tetramethylrhodamine isothiocyanate (TRITC) and the like are well known as fluorescent labeling compounds and are widely used in the fields of protein analysis and nucleic acid analysis. In the nucleic acid analysis, a DNA oligomer labeled with FITC or TRITC is used when the base sequence is analyzed by an automatic DNA sequencer, or it is used when a dynamic analysis of DNA is performed. In the case of base sequence analysis, generally, the number of molecules of the DNA fragment contained in each band after electrophoresis is about 1
It is in the range of × 10 -16 to 1 × 10 -18, which is the limit that can be detected by combining an optical system using a laser as a light source.
【0005】特開平2-191674号明細書にはインドシアニ
ン型の高蛍光性化合物が記載されているが、芳香環に直
接スルホン酸基を付加することによって水溶性を付与し
たものであるが、化合物内に複数個の反応性基を持って
おり、標識に際して架橋によって被標識化合物の変性を
起こし易い。Japanese Unexamined Patent Publication (Kokai) No. 2-191674 describes an indocyanine type highly fluorescent compound, which is water-soluble by directly adding a sulfonic acid group to an aromatic ring. Since the compound has a plurality of reactive groups, the compound to be labeled is likely to be modified by crosslinking during labeling.
【0006】また、特開平5-40097 号明細書に蛍光標識
用色素として記載されている化合物もやはり架橋の問題
があり、さらに、それ自体では各種官能基各種官能基と
反応できないため、あらかじめ活性化する操作が必要
で、目的標識体を得るまでに余分なステップを要する。Further, the compound described as a fluorescent labeling dye in JP-A-5-40097 also has a problem of cross-linking, and since it cannot react with various functional groups by itself, it is previously activated. It requires an additional step to obtain the desired labeled substance.
【0007】近年、ある系の中でのタンパクや核酸等の
微小な成分の挙動を、蛍光顕微鏡を用いて解析しようと
する試みが行なわれるようになってきた。そのために
は、 1分子を検出する必要があり、これは従来の蛍光標
識試薬では感度的に達成不可能なレベルである。また、
血清や試料抽出物中のウイルスや菌体の種類を特定する
場合に、現在では遺伝子増幅技術(PCR )で特定の遺伝
子だけを数千〜数万倍に増幅できるようになってきた
が、増幅の過程でノイズが入ることもあり、PCR を用い
ずに解析する必要性が出てきた。In recent years, attempts have been made to analyze the behavior of minute components such as proteins and nucleic acids in a system using a fluorescence microscope. To do so, it is necessary to detect one molecule, which is a level that cannot be achieved by sensitivity with conventional fluorescent labeling reagents. Also,
In the case of identifying the type of virus or bacterial cell in serum or sample extract, it is now possible to amplify only a specific gene several thousand to several tens of thousands times using gene amplification technology (PCR). Since noise may be included in the process, it became necessary to analyze without using PCR.
【0008】[0008]
【発明が解決しようとする課題】タンパクや核酸などの
微量な生体成分の検出には、蛍光や化学発光などの高感
度な分析法が適用されているが、通常はアトモレベル
で、 1〜数分子を計測するには現在の蛍光標識試薬では
感度的に不十分であり、モル吸光係数及び蛍光量子庫収
率の高い蛍光剤が必要となる。また、水系での使用が一
般的であるので、高い水溶性も要求される。加えて、表
紙前後で被標識体の性質が変化しないように位置選択性
な標識が必要であり、アミノ基よりもスルフヒドリル基
へ修飾できるラベル化剤であること及び被標識体同志を
架橋しないように分子内に一つのマレイミド基を持つこ
とが要求される。[Problems to be Solved by the Invention] Highly sensitive analytical methods such as fluorescence and chemiluminescence have been applied to the detection of minute amounts of biological components such as proteins and nucleic acids. The current fluorescent labeling reagent is insufficient in sensitivity to measure the above, and a fluorescent agent having high molar extinction coefficient and fluorescence quantum yield is required. Further, since it is generally used in an aqueous system, high water solubility is required. In addition, a regioselective label is required so that the properties of the labeled body do not change before and after the cover, and it is a labeling agent that can modify sulfhydryl groups rather than amino groups, and that it does not crosslink the labeled bodies. It is required to have one maleimide group in the molecule.
【0009】[0009]
【課題を解決するための手段】上記の課題を解決する本
発明の化合物は、次の一般式で示される水溶性インドシ
アニン化合物よりなるスルフヒドリル基を有する化合物
選択性蛍光標識試薬である。The compound of the present invention for solving the above-mentioned problems is a compound-selective fluorescent labeling reagent having a sulfhydryl group consisting of a water-soluble indocyanine compound represented by the following general formula.
【化3】 (式中、R1 、R2 はそれぞれ独立に水素原子、アルキ
ル基、アルコキシル基又はスルホネート基であり、R3
はアルキル基、スルホン酸アルキル基又はアンモニオア
ルキル基であり、nは 1〜3 の整数で、Xはアニオン種
であり、Yは炭素数が 1〜10のアルキル鎖又は酸素原
子、窒素原子及び硫黄原子のいずれか 1種以上を含む炭
素数が 1〜10のアルキル鎖である。)Embedded image (In the formula, R 1 and R 2 are each independently a hydrogen atom, an alkyl group, an alkoxyl group or a sulfonate group, and R 3
Is an alkyl group, an alkyl sulfonate group or an ammonioalkyl group, n is an integer of 1 to 3, X is an anion species, and Y is an alkyl chain having 1 to 10 carbon atoms or an oxygen atom, a nitrogen atom and An alkyl chain containing 1 to 10 carbon atoms and having 1 to 10 carbon atoms. )
【0010】本発明の化合物では、上記一般式のXはハ
ロゲン、酢酸、過塩素酸、炭酸などのアニオン種であ
る。In the compounds of the present invention, X in the above general formula is an anionic species such as halogen, acetic acid, perchloric acid, carbonic acid and the like.
【0011】本発明の化合物は被標識体のスルフヒドリ
ル基と反応し、被標識体にモル吸光係数及び蛍光量子収
率の高いインドシアニンの分光学的特性を付加させるこ
とができ、励起波長 550〜780nm 、蛍光波長 560〜800n
m の蛍光特性を持つ化合物とすることができる。The compound of the present invention can react with a sulfhydryl group of a substance to be labeled to add spectroscopic characteristics of indocyanine having a high molar extinction coefficient and a high fluorescence quantum yield to the substance to be labeled. 780nm, fluorescence wavelength 560 ~ 800n
The compound can have a fluorescence property of m 2.
【0012】本発明の化合物のスペクトル特性は、R
1 、R2 が水素原子、R3 がエチル基、Yが炭素数 5の
アルキル鎖、Xが塩素イオンの場合、nが 1〜3 のもの
のスペクトル特性を示せば表1のとおりである。The spectral characteristics of the compounds of the present invention are R
When 1 , R 2 is a hydrogen atom, R 3 is an ethyl group, Y is an alkyl chain having 5 carbon atoms, and X is a chlorine ion, the spectral characteristics of n of 1 to 3 are shown in Table 1.
【0013】[0013]
【表1】 [Table 1]
【0014】本発明の化合物は、いずれも文献未載の新
規化合物で、側鎖に水溶性基を含むもので、タンパクな
どを標識する場合に、そのタンパクが持つ水溶性を損な
うことなく標識できる。また、ピペラジノ環を側鎖に有
することにより側鎖が剛直になり、タンパクと標識した
色素部分とが疎水的な相互作用をせず、標識の前後でタ
ンパクの性質はそのまま維持される。さらに、マレイミ
ド基が一つの非対称化合物であるので、タンパク同志を
架橋しない。All of the compounds of the present invention are novel compounds which have not been published in the literature and have a water-soluble group in the side chain. When labeling a protein or the like, the compound can be labeled without impairing the water solubility of the protein. . Further, by having a piperazino ring in the side chain, the side chain becomes rigid, the protein and the labeled dye moiety do not interact hydrophobically, and the property of the protein is maintained as it is before and after labeling. Furthermore, since the maleimide group is one asymmetric compound, it does not crosslink the proteins.
【0015】本発明の化合物は、2,3,3-トリメチルイン
ドレニン又はそれらの誘導体を原料として合成される。
これらの原料はフィッシャーの合成法(E. Fischer and
O.Hess: Berichte, 17, 559(1883) など)に従って合
成するか、又は市販品を購入することで入手できる。原
料の窒素にアルキル基を導入した後、オルトぎ酸トリエ
チルなどと反応させてシアニン色素とし、その後ピペラ
ジノマレイミドと反応させてスルフヒドリル基選択性蛍
光標識試薬とする。The compound of the present invention is synthesized by using 2,3,3-trimethylindolenine or a derivative thereof as a raw material.
These raw materials were produced by the Fischer synthesis method (E. Fischer and
O. Hess: Berichte, 17 , 559 (1883), etc.) or commercially available. After introducing an alkyl group into the raw material nitrogen, it is reacted with triethyl orthoformate to give a cyanine dye, and then with piperazino maleimide to give a sulfhydryl group-selective fluorescent labeling reagent.
【0016】このようにして得られた化合物の代表例と
して化合物(A)〜(H)を以下に示す。Compounds (A) to (H) are shown below as typical examples of the compounds thus obtained.
【0017】[0017]
【化4】 [Chemical 4]
【0018】[0018]
【化5】 Embedded image
【0019】[0019]
【化6】 [Chemical 6]
【0020】[0020]
【化7】 [Chemical 7]
【0021】[0021]
【化8】 Embedded image
【0022】[0022]
【化9】 [Chemical 9]
【0023】[0023]
【化10】 [Chemical 10]
【0024】[0024]
【化11】 [Chemical 11]
【0025】以下、実施例によって本発明を具体的に説
明するが、本発明はその要旨を満たす限り、以下の実施
例によって制約されるものではない。Hereinafter, the present invention will be described in detail with reference to Examples, but the present invention is not limited to the following Examples as long as the gist thereof is satisfied.
【0026】実施例1 化合物(A)の合成 2,3,3-トリメチルインドレニン5.0g(31.4ミリモル)を
アセトニトリル100mlに溶解し、ヨードエタン5.9g(37.
8ミリモル)を加え一夜加熱還流した。反応液を減圧下
濃縮し、残渣にエーテルを加え、N-エチル- 2,3,3-トリ
メチルインドレニウム沃素塩の結晶を濾取した。灰赤色
結晶で、収量は9.1g、収率は92%であった。Example 1 Synthesis of Compound (A) 5.0 g (31.4 mmol) of 2,3,3-trimethylindolenine was dissolved in 100 ml of acetonitrile, and 5.9 g of iodoethane (37.
(8 mmol) was added and the mixture was heated under reflux overnight. The reaction solution was concentrated under reduced pressure, ether was added to the residue, and crystals of N-ethyl-2,3,3-trimethylindolenium iodide salt were collected by filtration. The crystals were gray-red and the yield was 9.1 g, 92%.
【0021】別に、2,3,3-トリメチルインドレニン5.0g
(31.4ミリモル)をジメチルホルムアミド100ml に溶か
し、6-ブロモヘキサン酸エチル8.4g(37.6ミリモル)を
加え100℃で一夜加熱した。反応液を減圧下濃縮し、残
渣をシリカゲルカラムクロマトグラフ(溶媒:メタノー
ル/クロロホルム)で分離精製し、 N-(5-エチルオキシ
カルボニルペンチル)- 2,3,3-トリメチルインドレニウ
ム臭素塩を得た。赤褐色オイルで、収量は3.4g、収率は
40%であった。Separately, 5.0 g of 2,3,3-trimethylindolenine
(31.4 mmol) was dissolved in 100 ml of dimethylformamide, 8.4 g (37.6 mmol) of ethyl 6-bromohexanoate was added, and the mixture was heated at 100 ° C overnight. The reaction mixture was concentrated under reduced pressure, and the residue was separated and purified by silica gel column chromatography (solvent: methanol / chloroform) to give N- (5-ethyloxycarbonylpentyl) -2,3,3-trimethylindolenium bromine salt. It was Reddish brown oil, yield 3.4g, yield
It was 40%.
【0022】N-エチル- 2,3,3-トリメチルインドレニン
沃素塩2.0g(6.3 ミリモル)及び N-(5-エチルオキシペ
ンチル)- 2,3,3-トリメチルインドレニウム臭素塩1.8g
(6.3 ミリモル)をピリジン10mlに溶解し、 110℃に加
熱した後、オルトぎ酸トリエチル1.6 ml(10.0ミリモ
ル)を加え、30分加熱した。反応液を減圧下濃縮し、ク
ロロホルムに溶解し、水洗を 3回繰返した。クロロホル
ム溶液を濃縮し、シリカゲルカラムクロマトグラフ(溶
媒:メタノール/クロロホルム)で分離精製し、N-エチ
ル- N'-(5-カルボキシペンチル)-3,3,3',3'-テトラメチ
ル- トリメチンインドシアニンを得た。緑色金属光沢結
晶で、収量は860mg 、収率は29%であった。2.0 g (6.3 mmol) of N-ethyl-2,3,3-trimethylindolenin iodine salt and 1.8 g of N- (5-ethyloxypentyl) -2,3,3-trimethylindolenium bromine salt
(6.3 mmol) was dissolved in 10 ml of pyridine, heated to 110 ° C., 1.6 ml (10.0 mmol) of triethyl orthoformate was added, and the mixture was heated for 30 minutes. The reaction solution was concentrated under reduced pressure, dissolved in chloroform, and washed with water three times. The chloroform solution was concentrated, separated and purified by silica gel column chromatography (solvent: methanol / chloroform), and N-ethyl-N '-(5-carboxypentyl) -3,3,3', 3'-tetramethyl-trimethyl. Got chin indocyanine. It was a green metallic luster crystal, and the yield was 860 mg and the yield was 29%.
【0023】この化合物 160mg(0.34ミリモル)をジメ
チルホルムアミド 2mlに溶かし、ピペラジノエチルマレ
イミド 100mg(0.35ミリモル)及びトリエチルアミン49
μl(0.36(ミリモル)を加え、 0℃に冷却しながらジ
シクロヘキシルカルボジイミド75mg(0.36ミリモル)を
加えた後、室温で一夜反応させた。反応液を濾過し、、
濾液を減圧下濃縮し、残渣をシリカゲルカラムクロマト
グラフ(溶媒:メタノール/クロロホルム)で分離精製
して化合物(A)を得た。黒赤色粉末で、収量は120mg
、収率は51%であった。160 mg (0.34 mmol) of this compound was dissolved in 2 ml of dimethylformamide, and 100 mg (0.35 mmol) of piperazinoethylmaleimide and 49 of triethylamine.
μl (0.36 (mmol) was added, and dicyclohexylcarbodiimide (75 mg, 0.36 mmol) was added while cooling to 0 ° C), and the mixture was reacted overnight at room temperature. The reaction solution was filtered,
The filtrate was concentrated under reduced pressure, and the residue was separated and purified by silica gel column chromatography (solvent: methanol / chloroform) to obtain compound (A). Black-red powder with a yield of 120 mg
The yield was 51%.
【0024】得られた化合物(A)をpH7.4 の PBSバッ
ファー(NaCl:8.0g, KCl:0.2g, Na2HPO4:11.5g, KH2PO4
/水1LL )に溶かした溶液の蛍光スペクトルを図1に示
す。The obtained compound (A) was added to a PBS buffer of pH 7.4 (NaCl: 8.0g, KCl: 0.2g, Na 2 HPO 4 : 11.5g, KH 2 PO 4).
Fig. 1 shows the fluorescence spectrum of the solution dissolved in / LL of water).
【0025】実施例2 化合物(B)の合成 N-エチル-N'-(5-カルボキシペンチル)-3,3,3',3'- テ
トラメチル- トリメチンインドシアニン 320mg(0.68ミ
リモル)を 5mlの30%発煙硫酸中へ少しづつ加えた。そ
のまま 1時間撹拌した後、炭酸水素ナトリウムを含む水
中へ注ぎ、析出してきた硫酸ナトリウムを濾過で除き、
濾液を減圧下濃縮した。残っている硫酸ナトリウムはメ
タノールに懸濁させ、濾過して除き、セファデックスLH
20/水を用いて分離精製し、N-エチル- N'-(5-カルボキ
シペンチル)-3,3,3',3'-テトラメチル- トリメチンイン
ドシアニン-5,5'-ジスルホン酸を得た。黒赤色固体で、
収量は310mg 、収率は70%であった。Example 2 Synthesis of compound (B) N-ethyl-N '-(5-carboxypentyl) -3,3,3', 3'-tetramethyl-trimethine indocyanine 320 mg (0.68 mmol) 5 ml Of 30% fuming sulfuric acid was added little by little. After stirring for 1 hour as it is, it is poured into water containing sodium hydrogen carbonate, and the precipitated sodium sulfate is removed by filtration.
The filtrate was concentrated under reduced pressure. Remaining sodium sulfate is suspended in methanol, filtered off, and separated by Sephadex LH.
Separation and purification using 20 / water to give N-ethyl-N '-(5-carboxypentyl) -3,3,3', 3'-tetramethyl-trimethine indocyanine-5,5'-disulfonic acid Obtained. A black-red solid,
The yield was 310 mg, and the yield was 70%.
【0026】N-エチル- N'-(5-カルボキシペンチル)-3,
3,3',3'-テトラメチル- トリメチンインドシアニン-5,
5'-ジスルホン酸 120mg(0.19ミリモル)を水/テトラ
ヒドロフラン(THF)混合溶媒に溶かし、ピペラジノ
エチルマレイミド65mg(0.22ミリモル)を加え、炭酸水
素ナトリウムで溶液のpHを6.5 に調整した後、ジシクロ
ヘキシルカルボジイミド48mg(0.23ミリモル)をTHF
に溶かして加え、室温で一夜撹拌した。析出したジシク
ロヘキシル尿素を濾過で除き、濾液を減圧下濃縮し、セ
ファデックスLH20/水で分離精製して化合物(B)を得
た。黒赤色固体で、収量は 145mg、収率は92%であっ
た。N-ethyl-N '-(5-carboxypentyl) -3,
3,3 ', 3'-Tetramethyl-trimethine indocyanine-5,
Dissolve 120 mg (0.19 mmol) of 5'-disulfonic acid in a water / tetrahydrofuran (THF) mixed solvent, add 65 mg (0.22 mmol) of piperazinoethylmaleimide, adjust the pH of the solution to 6.5 with sodium hydrogen carbonate, and then dicyclohexyl. Carbodiimide 48 mg (0.23 mmol) in THF
Was added to the solution, and the mixture was stirred overnight at room temperature. The precipitated dicyclohexylurea was removed by filtration, the filtrate was concentrated under reduced pressure, and separated and purified with Sephadex LH20 / water to obtain compound (B). It was a black-red solid and the yield was 145 mg and the yield was 92%.
【0027】実施例3 化合物(C)の合成 N-エチル- 2,3,3-トリメチルインドレニン沃素塩2.0g
(6.3 ミリモル)及び N-(5-エチルオキシカルボニルペ
ンチル)- 2,3,3-トリメチルインドレニウム臭素塩1.8g
(6.3 ミリモル)をピリジン10mlに溶解し、 110℃に加
熱した後、1,3,3-トリメトキシプロペン1.3g(9.8 ミリ
モル)を加え 1時間加熱した。反応液を減圧下濃縮し、
クロロホルムに溶解し水洗を 3回繰返した。クロロホル
ム溶液を濃縮し、シリカゲルカラムクロマトグラフ(溶
媒:メタノール/クロロホルム)で分離精製し、N-エチ
ル- N'-(5-カルボキシペンチル)-3,3,3',3'-テトラメチ
ル-ペンタメチンインドシアニンを得た。緑色金属光沢
結晶で、収量は710mg 、収率は23%であった。Example 3 Synthesis of compound (C) 2.0 g of N-ethyl-2,3,3-trimethylindolenin iodine salt
(6.3 mmol) and N- (5-ethyloxycarbonylpentyl) -2,3,3-trimethylindolenium bromine salt 1.8 g
(6.3 mmol) was dissolved in 10 ml of pyridine, heated to 110 ° C., 1.3 g (9.8 mmol) of 1,3,3-trimethoxypropene was added, and the mixture was heated for 1 hour. The reaction solution is concentrated under reduced pressure,
It was dissolved in chloroform and washed with water three times. The chloroform solution was concentrated, separated and purified by silica gel column chromatography (solvent: methanol / chloroform), and N-ethyl-N '-(5-carboxypentyl) -3,3,3', 3'-tetramethyl-penta. I got methine indocyanine. It was a green metallic luster crystal, and the yield was 710 mg and the yield was 23%.
【0028】化合物(A)の合成時と同様に、N-エチル
- N'-(5-カルボキシペンチル)-3,3,3',3'-テトラメチル
- ペンタメチンインドシアニン200mg (0.43ミリモル)
とピペラジノエチルマレイミドとを反応させ、シリカゲ
ルカラムクロマトグラフで単離生成して化合物(C)を
得た。黒青色固体で、収量は180mg 、収率は58%であっ
た。As in the synthesis of compound (A), N-ethyl
-N '-(5-carboxypentyl) -3,3,3', 3'-tetramethyl
-Pentamethine indocyanine 200 mg (0.43 mmol)
And piperazinoethylmaleimide were reacted and isolated and produced by silica gel column chromatography to obtain compound (C). It was a black-blue solid and the yield was 180 mg and the yield was 58%.
【0029】実施例4 化合物(A)を用いたタンパクの標識 牛血清アルブミン(BSA)12.5mgをpH8 の0.1Mリン酸
緩衝液2.5ml に溶かし、0.3Mのジチオスレイトール水溶
液10mlを加え、30℃で 5時間放置した。ファルマシアの
パックドカラムPD-10 を用いてpH7.4 の PBSバッファー
(NaCl:8.0g, KCl:0.2g, Na2HPO4:11.5g, KH2PO4/水1L
L )で分離精製した。得られた還元BSA溶液3.0ml に
化合物(A)の100mM 水溶液50mlを加え、25℃で一夜放
置した。標識されたタンパク画分を PD-10カラムを用
い、 PBSバファーで分離した。得られた3.0ml の画分を
凍結乾燥した。Example 4 Labeling of protein with compound (A) 12.5 mg of bovine serum albumin (BSA) was dissolved in 2.5 ml of 0.1 M phosphate buffer of pH 8 and 10 ml of 0.3 M dithiothreitol aqueous solution was added, It was left at ℃ for 5 hours. Using a Pharmacia packed column PD-10, PBS buffer at pH 7.4 (NaCl: 8.0g, KCl: 0.2g, Na 2 HPO 4 : 11.5g, KH 2 PO 4 / water 1L)
L) and separated and purified. 50 ml of a 100 mM aqueous solution of the compound (A) was added to 3.0 ml of the obtained reduced BSA solution, and the mixture was left at 25 ° C. overnight. The labeled protein fraction was separated with a PBS buffer using a PD-10 column. The obtained 3.0 ml fraction was freeze-dried.
【0030】化合物(A)を標識したBSAをpH7.4 の
PBSバッファーに溶かした溶液の蛍光スペクトルを図2
に示す。BSA labeled with compound (A) was adjusted to pH 7.4.
Fig. 2 shows the fluorescence spectrum of the solution dissolved in PBS buffer.
Shown in
【0031】標識タンパクの細胞内導入及び蛍光観察 ダルベッコ改変MEM培地(以下、DMEMと略記する)で
培養したNIH3T3細胞を用い、メリディアン社製のグラス
ボトムディシュのガラス上に細胞を付着させた。化合物
(A)を標識したBSA 1mgを PBSバッファー10mlに溶
かし、0.2 μmのフィルターを通し減菌水で 1/10に希
釈した。Intracellular introduction of labeled protein and fluorescent observation NIH3T3 cells cultured in Dulbecco's modified MEM medium (hereinafter abbreviated as DMEM) were used to attach the cells to the glass of a Meridian glass bottom dish. 1 mg of BSA labeled with the compound (A) was dissolved in 10 ml of PBS buffer, passed through a 0.2 μm filter and diluted 1/10 with sterile water.
【0032】化合物(A)をBSAに標識し、pH7.4 の
PBSバッファーに溶かした溶液の吸収スペクトルを図2
に示す。Compound (A) was labeled with BSA and adjusted to pH 7.4.
Figure 2 shows the absorption spectrum of the solution dissolved in PBS buffer.
Shown in
【0033】この溶液を再び0.2 μm のフィルターを通
した後、マイクロインジェクション用のシリカキャピラ
リーに入れ、 2kg/cm2程度の圧力を加えながら細胞に色
素標識BSAを導入した。この操作により 1細胞当り0.
1pl すなわち15ゼプトモルの色素BSAを導入したこと
になる。This solution was passed through a 0.2 μm filter again, put into a silica capillary for microinjection, and the dye-labeled BSA was introduced into the cells while applying a pressure of about 2 kg / cm 2 . By this operation, 0 per cell.
That is, 1 pl, that is, 15 zeptomoles of the dye BSA was introduced.
【0034】DMEMを捨て、PBS で線状を 4回繰返した
後、PBS バッファー中で落射蛍光顕微鏡(オリンパスOM
T-2 )を用い、蛍光観察した。蛍光はG励起のフィルタ
ーを通し、高感度CCDカメラを用いて検出した。その
結果、BSAをマイクロインジェクションした細胞のみ
を検出できた。After discarding DMEM and repeating the linear pattern four times with PBS, an epifluorescence microscope (Olympus OM was used in PBS buffer).
T-2) was used for fluorescence observation. Fluorescence was detected using a high sensitivity CCD camera after passing through a G excitation filter. As a result, only cells microinjected with BSA could be detected.
【0035】[0035]
【発明の効果】本発明の蛍光標識試薬はインドシアニン
を母核に持ちゼプトモルレベルの検出が可能であり、分
子内一つのマレイミド基を有するため、被標識体のスル
フヒドリル基と選択性に反応し、被標識体同志を架橋さ
せない。また、側鎖中のピペラジノ基は化合物に酸性〜
中性域で水溶性を与え、且つ側鎖を硬直にして色素とタ
ンパクの相互作用を低く押えてタンパクの特性を損なわ
ない。EFFECTS OF THE INVENTION The fluorescent labeling reagent of the present invention has indocyanine in the mother nucleus and can detect zeptomole level, and since it has one maleimide group in the molecule, it reacts selectively with the sulfhydryl group of the substance to be labeled. However, the labeled bodies do not cross-link. Also, the piperazino group in the side chain is acidic to the compound.
It imparts water-solubility in the neutral range, and the side chain is made rigid so that the interaction between the dye and the protein is suppressed and the protein properties are not impaired.
【図1】本発明の化合物(A)をpH7.4 の PBSバッファ
ーに溶かした溶液の吸収スペクトルを示す。FIG. 1 shows an absorption spectrum of a solution obtained by dissolving the compound (A) of the present invention in PBS buffer having a pH of 7.4.
【図2】本発明の化合物(A)をBSAに標識し、pH7.
4 の PBSバッファーに溶かした溶液の吸収スペクトルを
示す。FIG. 2: BSA labeled with the compound (A) of the present invention, pH 7.
The absorption spectrum of the solution of 4 in PBS buffer is shown.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C07D 207:448 209:10) ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Office reference number FI technical display location C07D 207: 448 209: 10)
Claims (2)
ニン化合物よりなるスルフヒドリル基を有する化合物選
択性蛍光標識試薬。 【化1】 (式中、R1 、R2 はそれぞれ独立に水素原子、アルキ
ル基、アルコキシル基又はスルホネート基であり、R3
はアルキル基、スルホン酸アルキル基又はアンモニオア
ルキル基であり、nは 1〜3 の整数で、Xはアニオン種
であり、Yは炭素数が 1〜10のアルキル鎖又は酸素原
子、窒素原子及び硫黄原子のいずれか 1種以上を含む炭
素数が 1〜10のアルキル鎖である。)1. A compound-selective fluorescent labeling reagent having a sulfhydryl group, which comprises a water-soluble indocyanine compound represented by the following general formula. Embedded image (In the formula, R 1 and R 2 are each independently a hydrogen atom, an alkyl group, an alkoxyl group or a sulfonate group, and R 3
Is an alkyl group, an alkyl sulfonate group or an ammonioalkyl group, n is an integer of 1 to 3, X is an anion species, and Y is an alkyl chain having 1 to 10 carbon atoms or an oxygen atom, a nitrogen atom and An alkyl chain containing 1 to 10 carbon atoms and having 1 to 10 carbon atoms. )
ル基、アルコキシル基又はスルホネート基であり、R3
はアルキル基、スルホン酸アルキル基又はアンモニオア
ルキル基であり、nは 1〜3 の整数で、Xはアニオン種
であり、Yは炭素数が 1〜10のアルキル鎖又は酸素原
子、窒素原子及び硫黄原子のいずれか 1種以上を含む炭
素数が 1〜10のアルキル鎖である。)で示される水溶性
インドシアニン化合物を対象物のスルフヒドリル基と反
応させ蛍光検出により高感度で測定する方法。2. The following general formula: (In the formula, R 1 and R 2 are each independently a hydrogen atom, an alkyl group, an alkoxyl group or a sulfonate group, and R 3
Is an alkyl group, an alkyl sulfonate group or an ammonioalkyl group, n is an integer of 1 to 3, X is an anion species, and Y is an alkyl chain having 1 to 10 carbon atoms or an oxygen atom, a nitrogen atom and An alkyl chain containing 1 to 10 carbon atoms and having 1 to 10 carbon atoms. ) The method of reacting a water-soluble indocyanine compound represented by the formula (4) with a sulfhydryl group of an object and measuring with high sensitivity by fluorescence detection.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7031864A JPH08198873A (en) | 1995-01-30 | 1995-01-30 | Compound-selective fluorescent labeling reagent with sulfhydryl group |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7031864A JPH08198873A (en) | 1995-01-30 | 1995-01-30 | Compound-selective fluorescent labeling reagent with sulfhydryl group |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH08198873A true JPH08198873A (en) | 1996-08-06 |
Family
ID=12342922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7031864A Withdrawn JPH08198873A (en) | 1995-01-30 | 1995-01-30 | Compound-selective fluorescent labeling reagent with sulfhydryl group |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH08198873A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007032363A1 (en) * | 2005-09-13 | 2007-03-22 | The University Of Tokyo | Novel maleimide derivative |
US7705150B2 (en) * | 2004-02-04 | 2010-04-27 | Biosearch Technologies, Inc. | Cyanine dyes |
-
1995
- 1995-01-30 JP JP7031864A patent/JPH08198873A/en not_active Withdrawn
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7705150B2 (en) * | 2004-02-04 | 2010-04-27 | Biosearch Technologies, Inc. | Cyanine dyes |
US8436153B2 (en) | 2004-02-04 | 2013-05-07 | Biosearch Technologies, Inc. | Cyanine dyes |
US9435796B2 (en) | 2004-02-04 | 2016-09-06 | Biosearch Technologies, Inc. | Cyanine dyes |
WO2007032363A1 (en) * | 2005-09-13 | 2007-03-22 | The University Of Tokyo | Novel maleimide derivative |
JP5292570B2 (en) * | 2005-09-13 | 2013-09-18 | 国立大学法人 東京大学 | New maleimide derivatives |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4554224B2 (en) | 4,7-dichlorofluorescein dye as a molecular probe | |
US5296599A (en) | Activated carbamates compounds | |
EP0410806B1 (en) | Novel fluorescent dye | |
US9127164B2 (en) | Fluorescent dyes and uses thereof | |
US5981747A (en) | Monomethine cyanines rigidized by a two-carbon chain | |
US6750346B2 (en) | Stable near-infrared (NIR) marker dyes based on benzopyrylium-polymethines | |
JP2010254993A (en) | Reactive heterocyclic-substituted 7-hydroxycoumarin and its complex | |
AU6874698A (en) | Glycoconjugated fluorescent labeling reagents | |
CS273617B2 (en) | Method of resorufine's derivatives production | |
CN110143966B (en) | A kind of spiropyran-naphthalimide derivative and its synthesis method and application | |
KR20240031282A (en) | Compound based cyanine, labeling dye, kit and contrast medium composition for biomolecule comprising the same | |
US11597842B2 (en) | Labeling dye and kit including same | |
US10739330B2 (en) | Carbopyronone compounds useful as diagnostic adjuvants | |
JP2003506567A (en) | Use of acylsulfonamide-substituted polymethine dyes as fluorescent dyes and / or markers | |
WO2005012579A2 (en) | Homodimeric cyanine dye dimer comprising aromatic, heteroaromatic, cyclic or heterocyclic linker moiety in nucleic acid reporter molecules | |
JP4098839B2 (en) | Indocyanine compounds | |
CA2178304A1 (en) | Rigidized monomethine cyanine dyes | |
DE69809248T2 (en) | INTERMEDIATE DYE COMPOUNDS AND METHOD FOR THE PRODUCTION OF COLOR SUBSTANCES | |
US6140041A (en) | Fluorescent dye | |
JP2001002951A (en) | New fluorescent pigment and its use as fluorescent marker | |
US20120016128A1 (en) | Rhodamine lactone phosphoramidites and polymers | |
CN101258220A (en) | Fluorescent dye compounds, conjugates and uses thereof | |
JP2004508448A (en) | Oxazine derivatives | |
CN116375692B (en) | Near infrared fluorescent molecular probe for detecting cysteine, preparation method and kit thereof | |
JPH08198873A (en) | Compound-selective fluorescent labeling reagent with sulfhydryl group |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20040720 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20040916 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20040916 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20051115 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051213 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20060130 |